ALI launches data repositoryUltrasound image-management systems developer ALI Technologies continues to expand its image archiving offerings to include modalities outside ultrasound. The Vancouver, BC-based company has introduced a scalable data
Ultrasound image-management systems developer ALI Technologies continues to expand its image archiving offerings to include modalities outside ultrasound. The Vancouver, BC-based company has introduced a scalable data repository that can be used for all types of medical images. ALI DataStore features a Windows NT platform and is designed to support integrated DICOM and HL7 connectivity through its use of open standards such as Internet network protocols and SQL relational database technology.
DataStores ability to exchange HL7 messages directly with various HIS/RIS products is appropriate for facilities requiring half a terabyte to over 10 terabytes of data storage annually, according to the company. The system is also being marketed to OEMs as a complement to image acquisition and diagnostic workstations.
Strategies to Reduce Disparities in Interventional Radiology Care
March 19th 2025In order to help address the geographic, racial, and socioeconomic barriers that limit patient access to interventional radiology (IR) care, these authors recommend a variety of measures ranging from increased patient and physician awareness of IR to mobile IR clinics and improved understanding of social determinants of health.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Study: Monitoring of Prostate MRI Exams Could Lead to 75 Percent Reduction of Gadolinium Contrast
March 17th 2025While DCE MRI was deemed helpful in over 67 percent of cases in which it was used, researchers found that monitored prostate MRI exams, which facilitated a 75 percent reduction of DCE MRI sequences, had comparable sensitivity for prostate cancer as non-monitored exams.